²ÝÁñ2024еس¶Ò»¶þ

Policies and Other Resources

Pharmacovigilance Quality Manual Policy Summary
Responsibilities of Pharmacovigilance System Stakeholders Policy Summary
²ÝÁñ2024еس¶Ò»¶þAnti-Bribery and Anti-Corruption Business Standards for Vendors and Agents
²ÝÁñ2024еس¶Ò»¶þAnti-Corruption Policy Summary
²ÝÁñ2024еس¶Ò»¶þAntitrust and Fair Competition Policy Summary
²ÝÁñ2024еس¶Ò»¶þAudit Committee
²ÝÁñ2024еس¶Ò»¶þClimate Change Policy
²ÝÁñ2024еس¶Ò»¶þCode of Business Conduct and Ethics
²ÝÁñ2024еس¶Ò»¶þCompliance
²ÝÁñ2024еس¶Ò»¶þCompliance Committee
²ÝÁñ2024еس¶Ò»¶þDiversity and Inclusion policy
²ÝÁñ2024еس¶Ò»¶þEnvironmental Stewardship Policy
²ÝÁñ2024еس¶Ò»¶þFair Competition and Antitrust Business Standards for Vendors and Agents
²ÝÁñ2024еس¶Ò»¶þHealth and Safety Policy
²ÝÁñ2024еس¶Ò»¶þPartnerships and Collaborations
²ÝÁñ2024еس¶Ò»¶þPolicy on Combating Trafficking in Persons
²ÝÁñ2024еس¶Ò»¶þPolicy on Prohibiting Discrimination, Harassment and Retaliation
Viatris’ Policy Statement Regarding Slavery and Human Trafficking
²ÝÁñ2024еس¶Ò»¶þReport on U.S. Opioid Abuse
²ÝÁñ2024еس¶Ò»¶þStandards for Interactions with Healthcare Professionals (“Standards”) Policy Summary
²ÝÁñ2024еس¶Ò»¶þStatement on its Policy Against the Use of its Products in Capital Punishment
²ÝÁñ2024еس¶Ò»¶þSupplier Code of Conduct
²ÝÁñ2024еس¶Ò»¶þWater Policy
Other Relevant Governance Documents